MAP2K7 and malignant colon neoplasm: By contrast, knocking down C1GalT1C1 decreases malignant behaviours and the signalling pathways, suggesting that the chaperone can promote malignant phenotypes of colon cancer cells, mainly via activation of the MEK/ERK and PI3K/Akt signalling pathways [27].